Normalization of glucose entry under the high glucose condition by phlorizin attenuates the high glucose-induced morphological and functional changes of cultured bovine retinal pericytes-Reference-Cited by-同舟云学术

Normalization of glucose entry under the high glucose condition by phlorizin attenuates the high glucose-induced morphological and functional changes of cultured bovine retinal pericytes

Published:1999-01 Issue:1 Volume:1453 Page:83-91
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Wakisaka Masanori,Yoshinari Mototaka,Asano Tamotsu,Iino Kenzo,Nakamura Shin,Takata Yutaka,Fujishima Masatoshi

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference38 articles.

1. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973;Pirart;Diabetes Care,1978

2. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N. Engl. J. Med. 329, 977–986.

3. Retinal vascular patterns;Kuwabara;Arch. Ophthalmol.,1963

4. Pericyte form and distribution in rat retinal and uveal capillaries;Tilton;Invest. Ophthalmol. Vis. Sci.,1985

5. Studies on diabetic retinopathy;Speise;Arch. Ophthalmol.,1968

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium–glucose cotransporter 2 inhibitor therapy reduces the administration frequency of steroid injection in patients with diabetic macular edema: A cohort study using the Japanese health insurance claims database;Journal of Diabetes Investigation;2024-06-14

2. Können SGLT-2-Inhibitoren das Risiko einer diabetischen Retinopathie vermindern?;Die Diabetologie;2024-04-04

3. Sodium‐glucose co‐transporter 2 inhibitor therapy reduces the administration frequency of anti‐vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti‐vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database;Diabetes, Obesity and Metabolism;2024-01-19

4. Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinopathy in Patients With Type 2 Diabetes;JAMA Network Open;2023-12-20

5. The presence of sodium glucose co-transporter 2 in mesangial cells and pericytes and its roles in mesangial lesions and in capillaries under diabetic and ischemic conditions;Diabetes Research and Clinical Practice;2022-10